Interesting... Jon just answered a question about commercialising 2591, and was quite clear that the plan is to NOT commercialise on our own and will look for partnering options most likely (with the construct to be determined), as we are not set up to do so.
However he did say, that may change over time depending on shareholder appetite
- Forums
- ASX - By Stock
- NEU
- Ann: 2024 Full Year Results webinar
NEU
neuren pharmaceuticals limited
Add to My Watchlist
5.76%
!
$13.10

Ann: 2024 Full Year Results webinar, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.10 |
Change
-0.800(5.76%) |
Mkt cap ! $1.629B |
Open | High | Low | Value | Volume |
$13.95 | $13.96 | $12.88 | $9.534M | 725.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 266 | $13.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.15 | 1619 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 667 | 13.080 |
2 | 154 | 13.000 |
1 | 77 | 12.930 |
1 | 39 | 12.920 |
1 | 21 | 12.900 |
Price($) | Vol. | No. |
---|---|---|
13.190 | 1305 | 1 |
13.560 | 2250 | 1 |
13.880 | 748 | 1 |
14.000 | 60 | 1 |
14.020 | 10000 | 1 |
Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |